niacin has been researched along with Acute Confusional Senile Dementia in 12 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Excerpt | Relevance | Reference |
---|---|---|
"Niacin (vitamin B3) is an essential nutrient that treats pellagra, and prior to the advent of statins, niacin was commonly used to counter dyslipidemia." | 5.41 | The Promise of Niacin in Neurology. ( Urgoiti, GR; Wuerch, E; Yong, VW, 2023) |
"Niacin serves as a high-affinity ligand for the receptor HCAR2 (GPR109A)." | 1.72 | The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease. ( Casali, BT; Coronel, I; Lamb, BT; Landreth, GE; Lasagna-Reeves, CA; Lin, PB; Martinez, P; Moutinho, M; Oblak, AL; Puntambekar, SS; Tsai, AP, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Moutinho, M | 1 |
Puntambekar, SS | 1 |
Tsai, AP | 1 |
Coronel, I | 1 |
Lin, PB | 1 |
Casali, BT | 1 |
Martinez, P | 1 |
Oblak, AL | 1 |
Lasagna-Reeves, CA | 1 |
Lamb, BT | 1 |
Landreth, GE | 1 |
Wuerch, E | 1 |
Urgoiti, GR | 1 |
Yong, VW | 1 |
Hosseini, L | 1 |
Mahmoudi, J | 1 |
Pashazadeh, F | 1 |
Salehi-Pourmehr, H | 1 |
Sadigh-Eteghad, S | 1 |
Qin, B | 1 |
Xun, P | 1 |
Jacobs, DR | 1 |
Zhu, N | 1 |
Daviglus, ML | 1 |
Reis, JP | 1 |
Steffen, LM | 1 |
Van Horn, L | 1 |
Sidney, S | 1 |
He, K | 1 |
Szymański, P | 1 |
Markowicz, M | 1 |
Mikiciuk-Olasik, E | 1 |
Lee, ST | 1 |
Chu, K | 1 |
Jung, KH | 1 |
Kim, JH | 1 |
Huh, JY | 1 |
Yoon, H | 1 |
Park, DK | 1 |
Lim, JY | 1 |
Kim, JM | 1 |
Jeon, D | 1 |
Ryu, H | 1 |
Lee, SK | 1 |
Kim, M | 1 |
Roh, JK | 1 |
Vega, GL | 2 |
Weiner, MF | 1 |
Lipton, AM | 1 |
Von Bergmann, K | 1 |
Lutjohann, D | 1 |
Moore, C | 1 |
Svetlik, D | 1 |
Baskin, F | 1 |
Rosenberg, RN | 1 |
Fang, X | 1 |
Hynan, LS | 1 |
Moore, CB | 1 |
Weiner, M | 1 |
Morris, MC | 1 |
Evans, DA | 1 |
Bienias, JL | 1 |
Scherr, PA | 1 |
Tangney, CC | 1 |
Hebert, LE | 1 |
Bennett, DA | 1 |
Wilson, RS | 1 |
Aggarwal, N | 1 |
Hankes, LV | 1 |
Coenen, HH | 1 |
Rota, E | 1 |
Langen, KJ | 1 |
Herzog, H | 1 |
Wutz, W | 1 |
Stoecklin, G | 1 |
Feinendegen, LE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Safety and Efficacy of Qualia Mind on Cognition in a Healthy Population[NCT04389723] | 60 participants (Actual) | Interventional | 2020-05-12 | Completed | |||
Research of Olfactory Neuroepithelial Tissue as a Potential Biomarker of Alzheimer Disease[NCT02129452] | 40 participants (Actual) | Observational | 2013-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for niacin and Acute Confusional Senile Dementia
Article | Year |
---|---|
The Promise of Niacin in Neurology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Nervous System Diseases; Neurology; Niacin; Pellag | 2023 |
Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apoptosis; Behavior, An | 2021 |
2 trials available for niacin and Acute Confusional Senile Dementia
Article | Year |
---|---|
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain; Cholesterol 24-Hydroxylase; Female; Humans; Hydroxycholesterols; Hyd | 2003 |
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Blood Platelets; Cholester | 2003 |
8 other studies available for niacin and Acute Confusional Senile Dementia
Article | Year |
---|---|
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Disease Progression; Mice | 2022 |
Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
Topics: Adult; Age Factors; Alzheimer Disease; Cognition; Cognition Disorders; Cohort Studies; Diet; Dietary | 2017 |
Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Acridines; Alzheimer Disease; Cholinesterase Inhibitors; Enzyme Activation; Hu | 2011 |
miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model.
Topics: Alzheimer Disease; Animals; Benzylamines; Brain; Brain-Derived Neurotrophic Factor; Dendritic Spines | 2012 |
Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Diet; Female; Humans; Hypolipidemic Agents; Male; Niac | 2004 |
Brain bonus with niacin?
Topics: Alzheimer Disease; Humans; Hypolipidemic Agents; Memory Disorders; Niacin; Vasodilator Agents | 2004 |
Researchers study effect of niacin on Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Food; Humans; Niacin | 2005 |
Effect of Huntington's and Alzheimer's diseases on the transport of nicotinic acid or nicotinamide across the human blood-brain barrier.
Topics: Alzheimer Disease; Blood-Brain Barrier; Brain; Humans; Huntington Disease; Niacin; Niacinamide; Tomo | 1991 |